| 0 |
LYMPHOID TISSUE HYPOPLASIA |
97 |
0.6340 |
| 1 |
THYMUS HYPOPLASIA |
96 |
0.5517 |
| 2 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
84 |
0.4590 |
| 3 |
RED BLOOD CELL SEDIMENTATION RATE |
107 |
0.3835 |
| 4 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1040 |
0.3759 |
| 5 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
92 |
0.3755 |
| 6 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
269 |
0.3741 |
| 7 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
526 |
0.3723 |
| 8 |
GRAFT DYSFUNCTION |
99 |
0.3474 |
| 9 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1214 |
0.3359 |
| 10 |
TRANSPLANT DYSFUNCTION |
591 |
0.3309 |
| 11 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
113 |
0.3104 |
| 12 |
CYSTITIS VIRAL |
117 |
0.3055 |
| 13 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
638 |
0.2995 |
| 14 |
VIRAL HAEMORRHAGIC CYSTITIS |
211 |
0.2963 |
| 15 |
ENCEPHALITIS CYTOMEGALOVIRUS |
128 |
0.2922 |
| 16 |
GRANULOMA SKIN |
235 |
0.2862 |
| 17 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
265 |
0.2862 |
| 18 |
ACUTE GRAFT VERSUS HOST DISEASE |
1306 |
0.2850 |
| 19 |
GRAFT VERSUS HOST DISEASE IN LIVER |
204 |
0.2849 |
| 20 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
367 |
0.2787 |
| 21 |
GRAFT VERSUS HOST DISEASE IN SKIN |
591 |
0.2680 |
| 22 |
PRODUCT DROPPER ISSUE |
202 |
0.2567 |
| 23 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1116 |
0.2524 |
| 24 |
SMOOTH MUSCLE CELL NEOPLASM |
105 |
0.2512 |
| 25 |
BK VIRUS INFECTION |
848 |
0.2512 |
| 26 |
SCLERAL HYPERAEMIA |
168 |
0.2467 |
| 27 |
GRAFT VERSUS HOST DISEASE |
1744 |
0.2423 |
| 28 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
387 |
0.2188 |
| 29 |
KAPOSI'S SARCOMA |
109 |
0.2171 |
| 30 |
CHRONIC ALLOGRAFT NEPHROPATHY |
167 |
0.2133 |
| 31 |
LYMPHOCELE |
140 |
0.2108 |
| 32 |
EPSTEIN-BARR VIRAEMIA |
229 |
0.2065 |
| 33 |
DISSEMINATED ASPERGILLOSIS |
97 |
0.2055 |
| 34 |
BLOOD PARATHYROID HORMONE DECREASED |
281 |
0.1895 |
| 35 |
ADENOVIRUS INFECTION |
535 |
0.1843 |
| 36 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
894 |
0.1755 |
| 37 |
HEART TRANSPLANT REJECTION |
182 |
0.1753 |
| 38 |
ASPERGILLOSIS |
229 |
0.1752 |
| 39 |
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
81 |
0.1727 |
| 40 |
FOREIGN BODY SENSATION IN EYES |
1088 |
0.1705 |
| 41 |
KIDNEY TRANSPLANT REJECTION |
818 |
0.1703 |
| 42 |
CHRONIC SPONTANEOUS URTICARIA |
196 |
0.1690 |
| 43 |
EPSTEIN-BARR VIRUS INFECTION |
1047 |
0.1674 |
| 44 |
TRANSPLANT REJECTION |
1311 |
0.1635 |
| 45 |
ENGRAFTMENT SYNDROME |
95 |
0.1607 |
| 46 |
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME |
125 |
0.1598 |
| 47 |
GINGIVAL HYPERTROPHY |
237 |
0.1561 |
| 48 |
CYTOMEGALOVIRUS VIRAEMIA |
690 |
0.1550 |
| 49 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
181 |
0.1508 |
| 50 |
OBLITERATIVE BRONCHIOLITIS |
197 |
0.1500 |
| 51 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
338 |
0.1489 |
| 52 |
CYSTITIS HAEMORRHAGIC |
598 |
0.1482 |
| 53 |
POLYOMAVIRUS VIRAEMIA |
155 |
0.1460 |
| 54 |
PNEUMONIA CYTOMEGALOVIRAL |
283 |
0.1456 |
| 55 |
SUPERFICIAL INJURY OF EYE |
158 |
0.1446 |
| 56 |
LUNG TRANSPLANT REJECTION |
95 |
0.1439 |
| 57 |
EYE IRRITATION |
8140 |
0.1413 |
| 58 |
LIVER TRANSPLANT REJECTION |
253 |
0.1407 |
| 59 |
CYTOMEGALOVIRUS INFECTION |
2328 |
0.1399 |
| 60 |
PARVOVIRUS B19 INFECTION |
123 |
0.1374 |
| 61 |
INSTILLATION SITE PAIN |
336 |
0.1355 |
| 62 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
741 |
0.1319 |
| 63 |
HUMAN HERPESVIRUS 6 INFECTION |
248 |
0.1311 |
| 64 |
PANNICULITIS |
309 |
0.1276 |
| 65 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
420 |
0.1270 |
| 66 |
CEREBRAL TOXOPLASMOSIS |
118 |
0.1263 |
| 67 |
VIRAEMIA |
174 |
0.1255 |
| 68 |
TRANSPLANT FAILURE |
305 |
0.1243 |
| 69 |
APLASTIC ANAEMIA |
620 |
0.1186 |
| 70 |
RENAL TUBULAR ATROPHY |
101 |
0.1145 |
| 71 |
GRAFT LOSS |
82 |
0.1131 |
| 72 |
MYCOBACTERIUM CHELONAE INFECTION |
83 |
0.1123 |
| 73 |
PRODUCT CONTAINER ISSUE |
962 |
0.1121 |
| 74 |
THROMBOTIC MICROANGIOPATHY |
1070 |
0.1097 |
| 75 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
232 |
0.1080 |
| 76 |
ENTHESOPATHY |
165 |
0.1054 |
| 77 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
247 |
0.1053 |
| 78 |
VENOOCCLUSIVE DISEASE |
262 |
0.1045 |
| 79 |
ENCEPHALITIS VIRAL |
123 |
0.1010 |
| 80 |
ERYTHRODERMIC PSORIASIS |
83 |
0.1007 |
| 81 |
RHEUMATOID NODULE |
276 |
0.1001 |
| 82 |
EYELID PAIN |
201 |
0.0988 |
| 83 |
SOFT TISSUE DISORDER |
109 |
0.0983 |
| 84 |
BLOOD IRON ABNORMAL |
96 |
0.0983 |
| 85 |
STEROID DEPENDENCE |
86 |
0.0979 |
| 86 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
157 |
0.0979 |
| 87 |
CYTOMEGALOVIRUS TEST POSITIVE |
169 |
0.0947 |
| 88 |
NEPHROPATHY TOXIC |
1060 |
0.0943 |
| 89 |
VENOOCCLUSIVE LIVER DISEASE |
446 |
0.0902 |
| 90 |
CYTOMEGALOVIRUS COLITIS |
207 |
0.0899 |
| 91 |
PSEUDOMONAL SEPSIS |
155 |
0.0884 |
| 92 |
KIDNEY FIBROSIS |
153 |
0.0881 |
| 93 |
SYSTEMIC MYCOSIS |
100 |
0.0856 |
| 94 |
JC VIRUS INFECTION |
136 |
0.0850 |
| 95 |
ORAL ADMINISTRATION COMPLICATION |
79 |
0.0849 |
| 96 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
630 |
0.0839 |
| 97 |
CYTOMEGALOVIRUS CHORIORETINITIS |
160 |
0.0820 |
| 98 |
TOXOPLASMOSIS |
87 |
0.0806 |
| 99 |
LYMPHOPROLIFERATIVE DISORDER |
236 |
0.0803 |
| 100 |
LEUKAEMIA RECURRENT |
134 |
0.0792 |
| 101 |
HISTIOCYTOSIS HAEMATOPHAGIC |
232 |
0.0781 |
| 102 |
BRONCHOPULMONARY ASPERGILLOSIS |
602 |
0.0776 |
| 103 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
728 |
0.0762 |
| 104 |
STENOTROPHOMONAS INFECTION |
103 |
0.0759 |
| 105 |
ALANINE AMINOTRANSFERASE ABNORMAL |
160 |
0.0758 |
| 106 |
RENAL TUBULAR INJURY |
92 |
0.0757 |
| 107 |
EYE DISCHARGE |
768 |
0.0738 |
| 108 |
INFECTION REACTIVATION |
82 |
0.0716 |
| 109 |
HIRSUTISM |
95 |
0.0714 |
| 110 |
EYE PAIN |
4023 |
0.0712 |
| 111 |
DRUG TOLERANCE DECREASED |
200 |
0.0711 |
| 112 |
VARICELLA ZOSTER VIRUS INFECTION |
147 |
0.0708 |
| 113 |
ENTEROBACTER INFECTION |
119 |
0.0707 |
| 114 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
156 |
0.0700 |
| 115 |
SECONDARY IMMUNODEFICIENCY |
84 |
0.0691 |
| 116 |
ENTEROCOCCAL INFECTION |
332 |
0.0686 |
| 117 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
174 |
0.0654 |
| 118 |
APLASIA PURE RED CELL |
225 |
0.0653 |
| 119 |
SKIN NECROSIS |
338 |
0.0651 |
| 120 |
MUCORMYCOSIS |
168 |
0.0646 |
| 121 |
CORNEAL ABRASION |
87 |
0.0634 |
| 122 |
STEM CELL TRANSPLANT |
158 |
0.0632 |
| 123 |
ASPERGILLUS INFECTION |
413 |
0.0629 |
| 124 |
TENOSYNOVITIS |
172 |
0.0623 |
| 125 |
ABNORMAL SENSATION IN EYE |
264 |
0.0614 |
| 126 |
EYELID IRRITATION |
154 |
0.0613 |
| 127 |
NOCARDIOSIS |
157 |
0.0613 |
| 128 |
PSEUDOMONAS INFECTION |
512 |
0.0596 |
| 129 |
HAEMOLYTIC URAEMIC SYNDROME |
138 |
0.0595 |
| 130 |
HYPOGAMMAGLOBULINAEMIA |
389 |
0.0592 |
| 131 |
CONCOMITANT DISEASE PROGRESSION |
115 |
0.0588 |
| 132 |
BACTERIAL SEPSIS |
191 |
0.0586 |
| 133 |
KLEBSIELLA INFECTION |
294 |
0.0581 |
| 134 |
CUSHINGOID |
186 |
0.0579 |
| 135 |
C-REACTIVE PROTEIN ABNORMAL |
371 |
0.0578 |
| 136 |
OCULAR DISCOMFORT |
643 |
0.0572 |
| 137 |
ERYTHEMA OF EYELID |
294 |
0.0542 |
| 138 |
HYPERTRICHOSIS |
100 |
0.0539 |
| 139 |
NEPHROTIC SYNDROME |
368 |
0.0536 |
| 140 |
PNEUMOMEDIASTINUM |
97 |
0.0536 |
| 141 |
PNEUMATOSIS INTESTINALIS |
153 |
0.0536 |
| 142 |
SYSTEMIC CANDIDA |
134 |
0.0533 |
| 143 |
NEPHRECTOMY |
79 |
0.0532 |
| 144 |
LACRIMATION INCREASED |
1590 |
0.0526 |
| 145 |
OCULAR HYPERAEMIA |
2480 |
0.0522 |
| 146 |
STAPHYLOCOCCAL BACTERAEMIA |
227 |
0.0522 |
| 147 |
NEOPLASM SKIN |
81 |
0.0521 |
| 148 |
PNEUMONIA KLEBSIELLA |
95 |
0.0516 |
| 149 |
PNEUMONIA VIRAL |
161 |
0.0505 |
| 150 |
PYODERMA GANGRENOSUM |
181 |
0.0503 |
| 151 |
CRYPTOCOCCOSIS |
81 |
0.0497 |
| 152 |
STAPHYLOCOCCAL SEPSIS |
243 |
0.0492 |
| 153 |
PNEUMONIA FUNGAL |
194 |
0.0491 |
| 154 |
APLASIA |
94 |
0.0480 |
| 155 |
HERPES SIMPLEX |
311 |
0.0478 |
| 156 |
OVARIAN CYST |
476 |
0.0476 |
| 157 |
MYCOBACTERIAL INFECTION |
82 |
0.0476 |
| 158 |
BRAIN ABSCESS |
116 |
0.0458 |
| 159 |
LEUKOENCEPHALOPATHY |
169 |
0.0453 |
| 160 |
DRY EYE |
2243 |
0.0449 |
| 161 |
LUPUS NEPHRITIS |
84 |
0.0449 |
| 162 |
BONE MARROW TRANSPLANT |
85 |
0.0448 |
| 163 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
487 |
0.0440 |
| 164 |
OPPORTUNISTIC INFECTION |
81 |
0.0438 |
| 165 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
430 |
0.0428 |
| 166 |
PUSTULAR PSORIASIS |
146 |
0.0425 |
| 167 |
SERUM FERRITIN INCREASED |
224 |
0.0424 |
| 168 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
149 |
0.0422 |
| 169 |
ESCHERICHIA SEPSIS |
122 |
0.0421 |
| 170 |
CAPILLARY LEAK SYNDROME |
87 |
0.0420 |
| 171 |
GLOMERULONEPHRITIS |
102 |
0.0416 |
| 172 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
104 |
0.0403 |
| 173 |
EYE PRURITUS |
1315 |
0.0391 |
| 174 |
ASTHENOPIA |
214 |
0.0389 |
| 175 |
ACTINIC KERATOSIS |
101 |
0.0389 |
| 176 |
BASAL CELL CARCINOMA |
606 |
0.0388 |
| 177 |
GROWTH RETARDATION |
114 |
0.0387 |
| 178 |
GRANULOMA |
134 |
0.0387 |
| 179 |
EYELID MARGIN CRUSTING |
111 |
0.0384 |
| 180 |
EYELID DISORDER |
88 |
0.0381 |
| 181 |
MUCOSAL INFLAMMATION |
988 |
0.0377 |
| 182 |
DEMYELINATION |
154 |
0.0375 |
| 183 |
BACTERAEMIA |
446 |
0.0375 |
| 184 |
SCLERODERMA |
136 |
0.0374 |
| 185 |
SYNOVITIS |
673 |
0.0373 |
| 186 |
PHOTOPHOBIA |
675 |
0.0359 |
| 187 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
121 |
0.0353 |
| 188 |
HAEMODIALYSIS |
295 |
0.0351 |
| 189 |
HEPATOSPLENOMEGALY |
90 |
0.0350 |
| 190 |
MULTI-ORGAN FAILURE |
604 |
0.0349 |
| 191 |
DRUG ERUPTION |
614 |
0.0346 |
| 192 |
BACTERIAL INFECTION |
646 |
0.0346 |
| 193 |
SERUM SICKNESS |
96 |
0.0344 |
| 194 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
79 |
0.0343 |
| 195 |
HAEMOLYSIS |
262 |
0.0339 |
| 196 |
CANDIDIASIS |
135 |
0.0336 |
| 197 |
SWELLING OF EYELID |
211 |
0.0336 |
| 198 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
83 |
0.0335 |
| 199 |
ESCHERICHIA INFECTION |
276 |
0.0335 |
| 200 |
HYPERCALCAEMIA |
414 |
0.0335 |
| 201 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
944 |
0.0333 |
| 202 |
SKIN PLAQUE |
281 |
0.0333 |
| 203 |
PRODUCT DELIVERY MECHANISM ISSUE |
178 |
0.0331 |
| 204 |
EYELIDS PRURITUS |
102 |
0.0327 |
| 205 |
LYMPHADENITIS |
79 |
0.0326 |
| 206 |
SQUAMOUS CELL CARCINOMA |
306 |
0.0325 |
| 207 |
RENAL TRANSPLANT |
117 |
0.0324 |
| 208 |
CLOSTRIDIUM DIFFICILE COLITIS |
338 |
0.0318 |
| 209 |
RHINOVIRUS INFECTION |
123 |
0.0316 |
| 210 |
SQUAMOUS CELL CARCINOMA OF SKIN |
190 |
0.0314 |
| 211 |
BLOOD CREATININE INCREASED |
2052 |
0.0314 |
| 212 |
RENAL TUBULAR NECROSIS |
306 |
0.0312 |
| 213 |
RENAL TUBULAR DISORDER |
87 |
0.0309 |
| 214 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
253 |
0.0306 |
| 215 |
IMMUNE THROMBOCYTOPENIA |
140 |
0.0305 |
| 216 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
197 |
0.0303 |
| 217 |
KERATITIS |
92 |
0.0302 |
| 218 |
RHEUMATOID FACTOR POSITIVE |
174 |
0.0301 |
| 219 |
BLEPHARITIS |
120 |
0.0299 |
| 220 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
469 |
0.0296 |
| 221 |
DIFFUSE LARGE B-CELL LYMPHOMA |
227 |
0.0294 |
| 222 |
LUNG INFILTRATION |
257 |
0.0291 |
| 223 |
B-CELL LYMPHOMA |
98 |
0.0288 |
| 224 |
PNEUMONIA BACTERIAL |
264 |
0.0287 |
| 225 |
HEPATIC FIBROSIS |
98 |
0.0285 |
| 226 |
DERMATITIS EXFOLIATIVE GENERALISED |
99 |
0.0284 |
| 227 |
EYE INFLAMMATION |
271 |
0.0284 |
| 228 |
C-REACTIVE PROTEIN INCREASED |
1027 |
0.0282 |
| 229 |
PULMONARY ALVEOLAR HAEMORRHAGE |
157 |
0.0280 |
| 230 |
DRUG TOLERANCE |
141 |
0.0278 |
| 231 |
RENAL FAILURE CHRONIC |
213 |
0.0277 |
| 232 |
PROTEINURIA |
523 |
0.0275 |
| 233 |
THERAPY PARTIAL RESPONDER |
426 |
0.0273 |
| 234 |
MYOPATHY |
234 |
0.0271 |
| 235 |
HYPERURICAEMIA |
110 |
0.0267 |
| 236 |
CONTRAINDICATED PRODUCT ADMINISTERED |
806 |
0.0266 |
| 237 |
ESCHERICHIA URINARY TRACT INFECTION |
113 |
0.0266 |
| 238 |
OLIGURIA |
165 |
0.0266 |
| 239 |
EYELID OEDEMA |
308 |
0.0265 |
| 240 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
101 |
0.0264 |
| 241 |
PYELONEPHRITIS |
229 |
0.0264 |
| 242 |
HEPATITIS B |
157 |
0.0260 |
| 243 |
RENAL IMPAIRMENT |
2185 |
0.0260 |
| 244 |
SEPTIC SHOCK |
1118 |
0.0257 |
| 245 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
444 |
0.0251 |
| 246 |
HYPOALBUMINAEMIA |
195 |
0.0251 |
| 247 |
DRUG LEVEL INCREASED |
414 |
0.0250 |
| 248 |
ULCER |
396 |
0.0249 |
| 249 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1360 |
0.0248 |
| 250 |
EYE INFECTION |
279 |
0.0247 |
| 251 |
ENCEPHALITIS |
170 |
0.0245 |
| 252 |
PULMONARY TUBERCULOSIS |
104 |
0.0243 |
| 253 |
INTRACRANIAL PRESSURE INCREASED |
135 |
0.0242 |
| 254 |
LYMPHOPENIA |
342 |
0.0242 |
| 255 |
BLOOD BILIRUBIN INCREASED |
651 |
0.0241 |
| 256 |
THERAPY NON-RESPONDER |
1078 |
0.0240 |
| 257 |
GUILLAIN-BARRE SYNDROME |
116 |
0.0240 |
| 258 |
PANCYTOPENIA |
1334 |
0.0238 |
| 259 |
IMMUNOSUPPRESSION |
210 |
0.0238 |
| 260 |
BONE EROSION |
84 |
0.0237 |
| 261 |
LIVER TRANSPLANT |
86 |
0.0236 |
| 262 |
OESOPHAGEAL CANDIDIASIS |
94 |
0.0236 |
| 263 |
HYPERBILIRUBINAEMIA |
244 |
0.0235 |
| 264 |
HERPES VIRUS INFECTION |
135 |
0.0234 |
| 265 |
TONGUE ULCERATION |
79 |
0.0234 |
| 266 |
HAEMORRHAGIC DIATHESIS |
83 |
0.0233 |
| 267 |
BONE MARROW FAILURE |
472 |
0.0232 |
| 268 |
TREATMENT FAILURE |
1924 |
0.0232 |
| 269 |
TONGUE DISORDER |
168 |
0.0232 |
| 270 |
DISSEMINATED INTRAVASCULAR COAGULATION |
324 |
0.0230 |
| 271 |
BLOOD UREA INCREASED |
385 |
0.0230 |
| 272 |
DRUG RESISTANCE |
590 |
0.0229 |
| 273 |
NEUROTOXICITY |
399 |
0.0227 |
| 274 |
SKIN PAPILLOMA |
91 |
0.0227 |
| 275 |
ENDOCARDITIS |
116 |
0.0226 |
| 276 |
HEPATIC FUNCTION ABNORMAL |
842 |
0.0225 |
| 277 |
ANURIA |
193 |
0.0224 |
| 278 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
160 |
0.0223 |
| 279 |
HAEMOLYTIC ANAEMIA |
199 |
0.0222 |
| 280 |
EYE SWELLING |
819 |
0.0220 |
| 281 |
PULMONARY HAEMORRHAGE |
172 |
0.0220 |
| 282 |
BRONCHIECTASIS |
145 |
0.0215 |
| 283 |
VISION BLURRED |
2947 |
0.0214 |
| 284 |
CONCOMITANT DISEASE AGGRAVATED |
132 |
0.0214 |
| 285 |
STREPTOCOCCAL INFECTION |
119 |
0.0214 |
| 286 |
AZOTAEMIA |
84 |
0.0210 |
| 287 |
SKIN ULCER |
542 |
0.0209 |
| 288 |
GENERALISED OEDEMA |
259 |
0.0209 |
| 289 |
CYTOPENIA |
254 |
0.0207 |
| 290 |
URINE OUTPUT DECREASED |
181 |
0.0207 |
| 291 |
SPLENOMEGALY |
240 |
0.0205 |
| 292 |
LOW BIRTH WEIGHT BABY |
162 |
0.0204 |
| 293 |
STAPHYLOCOCCAL INFECTION |
672 |
0.0204 |
| 294 |
BLOOD CREATINE INCREASED |
90 |
0.0203 |
| 295 |
NECROSIS |
113 |
0.0203 |
| 296 |
PSORIATIC ARTHROPATHY |
822 |
0.0202 |
| 297 |
FUNGAL INFECTION |
674 |
0.0202 |
| 298 |
ORGANISING PNEUMONIA |
100 |
0.0202 |
| 299 |
CANDIDA INFECTION |
340 |
0.0201 |
| 300 |
BREATH SOUNDS ABNORMAL |
99 |
0.0201 |
| 301 |
SKIN LESION |
550 |
0.0200 |
| 302 |
SEPSIS |
2197 |
0.0197 |
| 303 |
DYSLIPIDAEMIA |
100 |
0.0197 |
| 304 |
LEUKOPENIA |
977 |
0.0195 |
| 305 |
DRUG INTOLERANCE |
1867 |
0.0193 |
| 306 |
PAPILLOEDEMA |
87 |
0.0192 |
| 307 |
HYDRONEPHROSIS |
144 |
0.0192 |
| 308 |
LIVER FUNCTION TEST ABNORMAL |
558 |
0.0192 |
| 309 |
TOXIC ENCEPHALOPATHY |
97 |
0.0191 |
| 310 |
BLOOD PRESSURE DIASTOLIC INCREASED |
88 |
0.0190 |
| 311 |
SKIN MASS |
127 |
0.0190 |
| 312 |
RENAL FAILURE ACUTE |
807 |
0.0190 |
| 313 |
ACUTE MYELOID LEUKAEMIA |
293 |
0.0188 |
| 314 |
BLOOD URIC ACID INCREASED |
108 |
0.0187 |
| 315 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
192 |
0.0187 |
| 316 |
CACHEXIA |
96 |
0.0186 |
| 317 |
CHOLANGITIS |
114 |
0.0184 |
| 318 |
DISEASE RECURRENCE |
869 |
0.0182 |
| 319 |
HORDEOLUM |
79 |
0.0182 |
| 320 |
BRAIN OEDEMA |
229 |
0.0181 |
| 321 |
INCORRECT PRODUCT STORAGE |
237 |
0.0180 |
| 322 |
HYPERCHOLESTEROLAEMIA |
174 |
0.0180 |
| 323 |
SKIN INFECTION |
202 |
0.0180 |
| 324 |
PATHOGEN RESISTANCE |
164 |
0.0180 |
| 325 |
PRODUCT USE IN UNAPPROVED INDICATION |
4398 |
0.0177 |
| 326 |
MYASTHENIA GRAVIS |
143 |
0.0177 |
| 327 |
MYELODYSPLASTIC SYNDROME |
256 |
0.0177 |
| 328 |
FEBRILE NEUTROPENIA |
1174 |
0.0177 |
| 329 |
PRODUCT USE COMPLAINT |
278 |
0.0176 |
| 330 |
HEPATIC ENZYME ABNORMAL |
88 |
0.0176 |
| 331 |
ALANINE AMINOTRANSFERASE INCREASED |
1080 |
0.0176 |
| 332 |
RENAL CELL CARCINOMA |
85 |
0.0174 |
| 333 |
ASPARTATE AMINOTRANSFERASE INCREASED |
921 |
0.0173 |
| 334 |
RESPIRATORY FAILURE |
1262 |
0.0173 |
| 335 |
DRUG LEVEL DECREASED |
176 |
0.0173 |
| 336 |
TENDERNESS |
180 |
0.0173 |
| 337 |
CHOLESTASIS |
331 |
0.0172 |
| 338 |
MALABSORPTION |
90 |
0.0172 |
| 339 |
HEPATITIS C |
207 |
0.0171 |
| 340 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
767 |
0.0171 |
| 341 |
COVID-19 PNEUMONIA |
201 |
0.0170 |
| 342 |
REBOUND EFFECT |
192 |
0.0170 |
| 343 |
PRE-EXISTING CONDITION IMPROVED |
106 |
0.0170 |
| 344 |
TRANSAMINASES INCREASED |
377 |
0.0169 |
| 345 |
INFLAMMATION |
872 |
0.0169 |
| 346 |
PIGMENTATION DISORDER |
104 |
0.0168 |
| 347 |
HEPATOTOXICITY |
374 |
0.0168 |
| 348 |
NEPHROPATHY |
156 |
0.0167 |
| 349 |
HERPES ZOSTER |
956 |
0.0166 |
| 350 |
FOETAL GROWTH RESTRICTION |
101 |
0.0166 |
| 351 |
UROSEPSIS |
152 |
0.0165 |
| 352 |
RHABDOMYOLYSIS |
685 |
0.0164 |
| 353 |
ACUTE PULMONARY OEDEMA |
92 |
0.0164 |
| 354 |
NEUROLOGICAL SYMPTOM |
93 |
0.0163 |
| 355 |
PROTEIN URINE PRESENT |
81 |
0.0162 |
| 356 |
ORAL DISORDER |
119 |
0.0162 |
| 357 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
355 |
0.0160 |
| 358 |
EYE DISORDER |
523 |
0.0159 |
| 359 |
CATARACT |
947 |
0.0159 |
| 360 |
CATARACT OPERATION |
94 |
0.0158 |
| 361 |
VITREOUS FLOATERS |
155 |
0.0158 |
| 362 |
THERAPEUTIC RESPONSE DECREASED |
956 |
0.0158 |
| 363 |
ENTEROCOLITIS |
90 |
0.0156 |
| 364 |
PERIORBITAL SWELLING |
87 |
0.0154 |
| 365 |
HYPERTRANSAMINASAEMIA |
107 |
0.0154 |
| 366 |
GLAUCOMA |
295 |
0.0153 |
| 367 |
DEVICE RELATED INFECTION |
235 |
0.0153 |
| 368 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
379 |
0.0152 |
| 369 |
BLOOD ALBUMIN DECREASED |
121 |
0.0152 |
| 370 |
HEPATOMEGALY |
149 |
0.0151 |
| 371 |
FEAR OF INJECTION |
108 |
0.0151 |
| 372 |
AGRANULOCYTOSIS |
281 |
0.0151 |
| 373 |
HEPATITIS CHOLESTATIC |
91 |
0.0151 |
| 374 |
AUTOIMMUNE HEPATITIS |
105 |
0.0151 |
| 375 |
HAEMODYNAMIC INSTABILITY |
114 |
0.0149 |
| 376 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1062 |
0.0149 |
| 377 |
PULMONARY FIBROSIS |
286 |
0.0149 |
| 378 |
PERICARDIAL EFFUSION |
342 |
0.0148 |
| 379 |
GRAND MAL CONVULSION |
136 |
0.0147 |
| 380 |
HYDROCEPHALUS |
80 |
0.0147 |
| 381 |
PAPULE |
103 |
0.0146 |
| 382 |
INFECTION |
2112 |
0.0146 |
| 383 |
HEPATITIS |
373 |
0.0146 |
| 384 |
TOXIC EPIDERMAL NECROLYSIS |
221 |
0.0145 |
| 385 |
LIQUID PRODUCT PHYSICAL ISSUE |
106 |
0.0145 |
| 386 |
HEPATIC FAILURE |
437 |
0.0145 |
| 387 |
RALES |
84 |
0.0145 |
| 388 |
STOMATITIS |
877 |
0.0144 |
| 389 |
RENAL FAILURE |
1914 |
0.0144 |
| 390 |
TENDONITIS |
223 |
0.0144 |
| 391 |
PLATELET COUNT ABNORMAL |
87 |
0.0144 |
| 392 |
BLOOD PRESSURE SYSTOLIC INCREASED |
280 |
0.0143 |
| 393 |
TUBULOINTERSTITIAL NEPHRITIS |
269 |
0.0143 |
| 394 |
VIRAL INFECTION |
477 |
0.0143 |
| 395 |
GLUCOSE TOLERANCE IMPAIRED |
84 |
0.0142 |
| 396 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
86 |
0.0141 |
| 397 |
SHOCK HAEMORRHAGIC |
115 |
0.0141 |
| 398 |
ENCEPHALOPATHY |
346 |
0.0141 |
| 399 |
INTERSTITIAL LUNG DISEASE |
682 |
0.0141 |
| 400 |
EYELID PTOSIS |
143 |
0.0141 |
| 401 |
LYMPHADENOPATHY |
498 |
0.0141 |
| 402 |
JOINT EFFUSION |
97 |
0.0141 |
| 403 |
GASTROINTESTINAL INFECTION |
126 |
0.0140 |
| 404 |
PLATELET COUNT INCREASED |
182 |
0.0139 |
| 405 |
ANGIOPATHY |
78 |
0.0139 |
| 406 |
RESPIRATORY DISTRESS |
384 |
0.0139 |
| 407 |
ACUTE RESPIRATORY FAILURE |
267 |
0.0139 |
| 408 |
THROMBOCYTOPENIA |
1539 |
0.0137 |
| 409 |
SKIN ATROPHY |
79 |
0.0137 |
| 410 |
INTRAOCULAR PRESSURE INCREASED |
174 |
0.0136 |
| 411 |
PSORIASIS |
1776 |
0.0136 |
| 412 |
UVEITIS |
184 |
0.0136 |
| 413 |
VASCULITIS |
158 |
0.0135 |
| 414 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
118 |
0.0135 |
| 415 |
MOUTH ULCERATION |
285 |
0.0135 |
| 416 |
MALIGNANT MELANOMA |
181 |
0.0135 |
| 417 |
HYPERTRIGLYCERIDAEMIA |
79 |
0.0135 |
| 418 |
HYPERLIPIDAEMIA |
160 |
0.0134 |
| 419 |
VISUAL ACUITY REDUCED |
443 |
0.0133 |
| 420 |
HELICOBACTER INFECTION |
137 |
0.0133 |
| 421 |
DUODENAL ULCER PERFORATION |
99 |
0.0133 |
| 422 |
EYE MOVEMENT DISORDER |
91 |
0.0133 |
| 423 |
MULTIPLE ALLERGIES |
103 |
0.0131 |
| 424 |
OSTEOPENIA |
198 |
0.0130 |
| 425 |
MYOSITIS |
117 |
0.0130 |
| 426 |
FOOT DEFORMITY |
144 |
0.0130 |
| 427 |
HAEMORRHAGE INTRACRANIAL |
194 |
0.0130 |
| 428 |
ASCITES |
381 |
0.0129 |
| 429 |
RHEUMATOID ARTHRITIS |
1470 |
0.0129 |
| 430 |
EXPIRED PRODUCT ADMINISTERED |
427 |
0.0128 |
| 431 |
ORAL CANDIDIASIS |
169 |
0.0128 |
| 432 |
END STAGE RENAL DISEASE |
233 |
0.0128 |
| 433 |
ANGIOEDEMA |
564 |
0.0127 |
| 434 |
LYMPHOMA |
197 |
0.0127 |
| 435 |
HAND DEFORMITY |
167 |
0.0127 |
| 436 |
RENAL DISORDER |
588 |
0.0126 |
| 437 |
GASTROENTERITIS |
183 |
0.0125 |
| 438 |
HAEMATURIA |
426 |
0.0124 |
| 439 |
HAIR GROWTH ABNORMAL |
86 |
0.0124 |
| 440 |
PRODUCT PACKAGING ISSUE |
118 |
0.0124 |
| 441 |
DIALYSIS |
175 |
0.0123 |
| 442 |
IMPAIRED GASTRIC EMPTYING |
168 |
0.0123 |
| 443 |
CARDIAC FAILURE ACUTE |
82 |
0.0123 |
| 444 |
PETECHIAE |
128 |
0.0123 |
| 445 |
HEPATIC CIRRHOSIS |
230 |
0.0122 |
| 446 |
PYREXIA |
4229 |
0.0122 |
| 447 |
RASH PUSTULAR |
89 |
0.0122 |
| 448 |
SKIN HYPERPIGMENTATION |
105 |
0.0122 |
| 449 |
AUTOIMMUNE DISORDER |
119 |
0.0122 |
| 450 |
HEPATIC ENZYME INCREASED |
831 |
0.0122 |
| 451 |
ARTHROPATHY |
674 |
0.0121 |
| 452 |
PLATELET COUNT DECREASED |
1292 |
0.0121 |
| 453 |
ACUTE KIDNEY INJURY |
1844 |
0.0120 |
| 454 |
IMMUNE SYSTEM DISORDER |
158 |
0.0120 |
| 455 |
LUNG INFECTION |
186 |
0.0120 |
| 456 |
RETINAL DETACHMENT |
110 |
0.0120 |
| 457 |
LARGE INTESTINE PERFORATION |
83 |
0.0119 |
| 458 |
ARTHRITIS |
940 |
0.0119 |
| 459 |
CELLULITIS |
602 |
0.0119 |
| 460 |
CONJUNCTIVITIS |
221 |
0.0119 |
| 461 |
ABSCESS |
189 |
0.0118 |
| 462 |
DRUG TOXICITY |
161 |
0.0118 |
| 463 |
DRUG INTERACTION |
1874 |
0.0118 |
| 464 |
MADAROSIS |
137 |
0.0118 |
| 465 |
HAEMATOCRIT DECREASED |
234 |
0.0118 |
| 466 |
RETINAL HAEMORRHAGE |
84 |
0.0118 |
| 467 |
ORAL HERPES |
230 |
0.0118 |
| 468 |
PLEURAL EFFUSION |
716 |
0.0118 |
| 469 |
OEDEMA |
638 |
0.0118 |
| 470 |
DERMATITIS |
246 |
0.0117 |
| 471 |
ANOREXIA |
151 |
0.0117 |
| 472 |
HYPERTENSION |
2471 |
0.0117 |
| 473 |
BLOOD PRESSURE DIASTOLIC DECREASED |
86 |
0.0116 |
| 474 |
GLOMERULAR FILTRATION RATE DECREASED |
143 |
0.0116 |
| 475 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
557 |
0.0116 |
| 476 |
LUNG DISORDER |
564 |
0.0115 |
| 477 |
OFF LABEL USE |
10019 |
0.0114 |
| 478 |
LEUKOCYTOSIS |
207 |
0.0114 |
| 479 |
CLOSTRIDIUM DIFFICILE INFECTION |
249 |
0.0114 |
| 480 |
OSTEOMYELITIS |
206 |
0.0114 |
| 481 |
SCRATCH |
120 |
0.0114 |
| 482 |
MALNUTRITION |
127 |
0.0113 |
| 483 |
APHTHOUS ULCER |
88 |
0.0113 |
| 484 |
DIARRHOEA HAEMORRHAGIC |
106 |
0.0113 |
| 485 |
ATELECTASIS |
109 |
0.0113 |
| 486 |
INFUSION RELATED REACTION |
745 |
0.0112 |
| 487 |
OSTEOPOROSIS |
460 |
0.0112 |
| 488 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
790 |
0.0111 |
| 489 |
SKIN DISORDER |
370 |
0.0111 |
| 490 |
PRODUCT ADMINISTRATION INTERRUPTED |
87 |
0.0111 |
| 491 |
ORAL PAIN |
247 |
0.0110 |
| 492 |
RESPIRATORY TRACT INFECTION |
285 |
0.0109 |
| 493 |
CONDITION AGGRAVATED |
3324 |
0.0109 |
| 494 |
PRODUCT DOSE OMISSION |
713 |
0.0109 |
| 495 |
LIVER DISORDER |
483 |
0.0109 |
| 496 |
ACIDOSIS |
83 |
0.0108 |
| 497 |
JAUNDICE |
292 |
0.0108 |
| 498 |
PURPURA |
96 |
0.0108 |
| 499 |
PNEUMOTHORAX |
172 |
0.0108 |
| 500 |
HAEMATOTOXICITY |
103 |
0.0108 |
| 501 |
HYPOXIA |
380 |
0.0108 |
| 502 |
PHOTOSENSITIVITY REACTION |
178 |
0.0108 |
| 503 |
HAEMOGLOBIN DECREASED |
1104 |
0.0107 |
| 504 |
HYPERKALAEMIA |
376 |
0.0107 |
| 505 |
RENAL CYST |
85 |
0.0107 |
| 506 |
FIBROMYALGIA |
260 |
0.0107 |
| 507 |
WOUND INFECTION |
117 |
0.0107 |
| 508 |
PNEUMONIA |
3455 |
0.0107 |
| 509 |
ARTHROPOD BITE |
79 |
0.0106 |
| 510 |
PRODUCT STORAGE ERROR |
932 |
0.0106 |
| 511 |
HYPERTENSIVE CRISIS |
118 |
0.0106 |
| 512 |
QUALITY OF LIFE DECREASED |
141 |
0.0105 |
| 513 |
COAGULOPATHY |
175 |
0.0105 |
| 514 |
BLOOD MAGNESIUM DECREASED |
90 |
0.0104 |
| 515 |
PULMONARY CONGESTION |
137 |
0.0104 |
| 516 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
299 |
0.0104 |
| 517 |
RASH PRURITIC |
562 |
0.0104 |
| 518 |
HEPATIC STEATOSIS |
193 |
0.0104 |
| 519 |
POOR QUALITY PRODUCT ADMINISTERED |
109 |
0.0103 |
| 520 |
ANKYLOSING SPONDYLITIS |
136 |
0.0103 |
| 521 |
IMMUNODEFICIENCY |
153 |
0.0103 |
| 522 |
FACIAL PAIN |
91 |
0.0102 |
| 523 |
HEPATIC ENCEPHALOPATHY |
95 |
0.0102 |
| 524 |
PERICARDITIS |
171 |
0.0102 |
| 525 |
DIABETES MELLITUS |
775 |
0.0102 |
| 526 |
DISEASE PROGRESSION |
1197 |
0.0101 |
| 527 |
OSTEOARTHRITIS |
428 |
0.0101 |
| 528 |
MYOCLONUS |
120 |
0.0101 |
| 529 |
NEUTROPENIA |
1368 |
0.0101 |
| 530 |
CYSTITIS |
320 |
0.0100 |
| 531 |
DRUG INEFFECTIVE |
13231 |
0.0100 |
| 532 |
NO THERAPEUTIC RESPONSE |
122 |
0.0100 |
| 533 |
SKIN CANCER |
213 |
0.0099 |
| 534 |
MACULAR DEGENERATION |
118 |
0.0099 |
| 535 |
PRODUCT ADMINISTRATION ERROR |
199 |
0.0098 |
| 536 |
UPPER-AIRWAY COUGH SYNDROME |
81 |
0.0098 |
| 537 |
SUBARACHNOID HAEMORRHAGE |
100 |
0.0098 |
| 538 |
PERITONITIS |
203 |
0.0098 |
| 539 |
THERAPY CESSATION |
503 |
0.0098 |
| 540 |
ANAEMIA |
1866 |
0.0098 |
| 541 |
URTICARIA |
1636 |
0.0098 |
| 542 |
CARDIOMEGALY |
120 |
0.0097 |
| 543 |
CHOLECYSTITIS |
116 |
0.0097 |
| 544 |
JOINT RANGE OF MOTION DECREASED |
130 |
0.0097 |
| 545 |
ANAPHYLACTIC REACTION |
535 |
0.0097 |
| 546 |
SECRETION DISCHARGE |
121 |
0.0097 |
| 547 |
RASH MACULO-PAPULAR |
211 |
0.0095 |
| 548 |
SHOCK |
218 |
0.0095 |
| 549 |
ELECTROLYTE IMBALANCE |
110 |
0.0095 |
| 550 |
VITAMIN D DEFICIENCY |
92 |
0.0094 |
| 551 |
POST PROCEDURAL COMPLICATION |
181 |
0.0094 |
| 552 |
OSTEONECROSIS |
309 |
0.0094 |
| 553 |
DIPLOPIA |
244 |
0.0094 |
| 554 |
JOINT SWELLING |
1131 |
0.0094 |
| 555 |
EYE HAEMORRHAGE |
125 |
0.0094 |
| 556 |
PHARYNGITIS |
116 |
0.0093 |
| 557 |
ILEUS |
116 |
0.0093 |
| 558 |
PEMPHIGUS |
116 |
0.0093 |
| 559 |
EAR DISCOMFORT |
95 |
0.0092 |
| 560 |
OESOPHAGITIS |
101 |
0.0092 |
| 561 |
UPPER RESPIRATORY TRACT INFECTION |
427 |
0.0092 |
| 562 |
SCIATICA |
146 |
0.0091 |
| 563 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
325 |
0.0091 |
| 564 |
VISUAL IMPAIRMENT |
1132 |
0.0091 |
| 565 |
PRODUCT USE ISSUE |
1715 |
0.0091 |
| 566 |
CEREBRAL INFARCTION |
222 |
0.0091 |
| 567 |
IMPAIRED HEALING |
297 |
0.0090 |
| 568 |
PREMATURE DELIVERY |
144 |
0.0090 |
| 569 |
DRUG-INDUCED LIVER INJURY |
283 |
0.0090 |
| 570 |
ALTERED STATE OF CONSCIOUSNESS |
195 |
0.0090 |
| 571 |
GOUT |
161 |
0.0090 |
| 572 |
NODULE |
117 |
0.0090 |
| 573 |
STATUS EPILEPTICUS |
101 |
0.0089 |
| 574 |
POLYNEUROPATHY |
107 |
0.0089 |
| 575 |
HYPERSENSITIVITY |
1649 |
0.0089 |
| 576 |
GINGIVAL BLEEDING |
121 |
0.0089 |
| 577 |
HEMIPARESIS |
150 |
0.0088 |
| 578 |
MUSCULOSKELETAL DISORDER |
168 |
0.0088 |
| 579 |
ADRENAL INSUFFICIENCY |
107 |
0.0088 |
| 580 |
JOINT INJURY |
188 |
0.0088 |
| 581 |
PULMONARY MASS |
131 |
0.0088 |
| 582 |
CEREBRAL HAEMORRHAGE |
314 |
0.0088 |
| 583 |
DECREASED IMMUNE RESPONSIVENESS |
86 |
0.0088 |
| 584 |
LIVER FUNCTION TEST INCREASED |
188 |
0.0087 |
| 585 |
BURNING SENSATION |
613 |
0.0087 |
| 586 |
PULMONARY HYPERTENSION |
182 |
0.0087 |
| 587 |
MASS |
122 |
0.0087 |
| 588 |
MUSCULOSKELETAL STIFFNESS |
764 |
0.0087 |
| 589 |
PREMATURE BABY |
262 |
0.0087 |
| 590 |
SKIN HAEMORRHAGE |
129 |
0.0087 |
| 591 |
WOUND |
243 |
0.0087 |
| 592 |
EAR PAIN |
169 |
0.0087 |
| 593 |
BLOOD POTASSIUM INCREASED |
141 |
0.0087 |
| 594 |
BLOOD CHOLESTEROL INCREASED |
403 |
0.0086 |
| 595 |
PANCREATITIS ACUTE |
194 |
0.0086 |
| 596 |
MYELOSUPPRESSION |
310 |
0.0086 |
| 597 |
CAESAREAN SECTION |
100 |
0.0086 |
| 598 |
MITRAL VALVE INCOMPETENCE |
97 |
0.0086 |
| 599 |
SINUSITIS |
873 |
0.0085 |
| 600 |
PAIN OF SKIN |
229 |
0.0085 |
| 601 |
HEPATIC CYTOLYSIS |
108 |
0.0085 |
| 602 |
ERYTHEMA |
1735 |
0.0084 |
| 603 |
PNEUMONITIS |
228 |
0.0084 |
| 604 |
URINARY TRACT INFECTION |
1425 |
0.0083 |
| 605 |
SCAB |
95 |
0.0083 |
| 606 |
RESPIRATORY DISORDER |
249 |
0.0083 |
| 607 |
METABOLIC ACIDOSIS |
266 |
0.0083 |
| 608 |
WHITE BLOOD CELL COUNT INCREASED |
319 |
0.0083 |
| 609 |
DYSURIA |
305 |
0.0083 |
| 610 |
CONVULSION |
473 |
0.0083 |
| 611 |
BLOOD TRIGLYCERIDES INCREASED |
146 |
0.0083 |
| 612 |
BODY TEMPERATURE INCREASED |
168 |
0.0082 |
| 613 |
RED BLOOD CELL COUNT DECREASED |
235 |
0.0082 |
| 614 |
GASTRIC ULCER |
156 |
0.0082 |
| 615 |
MYOCARDITIS |
94 |
0.0082 |
| 616 |
RHINORRHOEA |
526 |
0.0081 |
| 617 |
EPISTAXIS |
608 |
0.0081 |
| 618 |
ACNE |
614 |
0.0081 |
| 619 |
JOINT DISLOCATION |
85 |
0.0080 |
| 620 |
LYMPHOCYTE COUNT DECREASED |
142 |
0.0080 |
| 621 |
TACHYPNOEA |
109 |
0.0080 |
| 622 |
COLITIS |
303 |
0.0080 |
| 623 |
LIVER INJURY |
195 |
0.0079 |
| 624 |
PRODUCT PRESCRIBING ISSUE |
173 |
0.0079 |
| 625 |
ATAXIA |
94 |
0.0079 |
| 626 |
BRONCHITIS |
586 |
0.0079 |
| 627 |
ACUTE HEPATIC FAILURE |
108 |
0.0079 |
| 628 |
GASTROINTESTINAL DISORDER |
708 |
0.0079 |
| 629 |
NECK PAIN |
439 |
0.0078 |
| 630 |
HEPATOCELLULAR INJURY |
111 |
0.0078 |
| 631 |
DERMATITIS CONTACT |
89 |
0.0078 |
| 632 |
CENTRAL NERVOUS SYSTEM LESION |
107 |
0.0078 |
| 633 |
SEASONAL ALLERGY |
110 |
0.0078 |
| 634 |
MELAENA |
171 |
0.0078 |
| 635 |
GASTRITIS |
203 |
0.0077 |
| 636 |
PRESCRIBED UNDERDOSE |
153 |
0.0077 |
| 637 |
TRANSFUSION |
80 |
0.0076 |
| 638 |
BLOOD PRESSURE INCREASED |
1167 |
0.0076 |
| 639 |
OBESITY |
121 |
0.0076 |
| 640 |
ACCIDENTAL EXPOSURE TO PRODUCT |
782 |
0.0076 |
| 641 |
CARPAL TUNNEL SYNDROME |
106 |
0.0076 |
| 642 |
FLUID OVERLOAD |
110 |
0.0076 |
| 643 |
CHRONIC KIDNEY DISEASE |
573 |
0.0075 |
| 644 |
SNEEZING |
169 |
0.0075 |
| 645 |
METASTASES TO LUNG |
87 |
0.0075 |
| 646 |
PERIPHERAL SWELLING |
1160 |
0.0075 |
| 647 |
UPPER LIMB FRACTURE |
150 |
0.0075 |
| 648 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
297 |
0.0075 |
| 649 |
ROTATOR CUFF SYNDROME |
96 |
0.0075 |
| 650 |
DIVERTICULITIS |
207 |
0.0075 |
| 651 |
BLOOD PRESSURE FLUCTUATION |
178 |
0.0074 |
| 652 |
BLINDNESS |
301 |
0.0074 |
| 653 |
INFLUENZA |
821 |
0.0074 |
| 654 |
PRODUCT PRESCRIBING ERROR |
175 |
0.0073 |
| 655 |
SINUS CONGESTION |
99 |
0.0073 |
| 656 |
ALOPECIA |
1438 |
0.0073 |
| 657 |
SINUS DISORDER |
145 |
0.0073 |
| 658 |
SCAR |
125 |
0.0073 |
| 659 |
CIRCULATORY COLLAPSE |
124 |
0.0073 |
| 660 |
HYPOTHYROIDISM |
232 |
0.0073 |
| 661 |
INTENTIONAL PRODUCT USE ISSUE |
636 |
0.0073 |
| 662 |
WHITE BLOOD CELL COUNT DECREASED |
777 |
0.0072 |
| 663 |
INTESTINAL PERFORATION |
80 |
0.0071 |
| 664 |
DEAFNESS |
186 |
0.0071 |
| 665 |
PRURITUS |
2733 |
0.0071 |
| 666 |
PULMONARY OEDEMA |
318 |
0.0071 |
| 667 |
LOCALISED INFECTION |
171 |
0.0071 |
| 668 |
CARDIAC FAILURE |
567 |
0.0071 |
| 669 |
SKIN FISSURES |
138 |
0.0071 |
| 670 |
PRODUCTIVE COUGH |
337 |
0.0071 |
| 671 |
FEEDING DISORDER |
143 |
0.0070 |
| 672 |
GASTROINTESTINAL HAEMORRHAGE |
588 |
0.0070 |
| 673 |
SLEEP APNOEA SYNDROME |
134 |
0.0070 |
| 674 |
MOBILITY DECREASED |
504 |
0.0070 |
| 675 |
COVID-19 |
1227 |
0.0070 |
| 676 |
GENERAL PHYSICAL HEALTH DETERIORATION |
808 |
0.0070 |
| 677 |
OEDEMA PERIPHERAL |
849 |
0.0070 |
| 678 |
FACE OEDEMA |
117 |
0.0069 |
| 679 |
NERVOUS SYSTEM DISORDER |
216 |
0.0069 |
| 680 |
MUSCULOSKELETAL PAIN |
359 |
0.0068 |
| 681 |
HYPERGLYCAEMIA |
248 |
0.0068 |
| 682 |
MUSCULAR WEAKNESS |
761 |
0.0067 |
| 683 |
GLOSSODYNIA |
149 |
0.0066 |
| 684 |
BLISTER |
373 |
0.0066 |
| 685 |
SWELLING FACE |
432 |
0.0066 |
| 686 |
OROPHARYNGEAL PAIN |
613 |
0.0066 |
| 687 |
GASTROENTERITIS VIRAL |
119 |
0.0066 |
| 688 |
DYSPNOEA EXERTIONAL |
248 |
0.0066 |
| 689 |
NEUTROPHIL COUNT DECREASED |
268 |
0.0066 |
| 690 |
ABDOMINAL PAIN |
1529 |
0.0066 |
| 691 |
HYPOMAGNESAEMIA |
91 |
0.0065 |
| 692 |
DRUG EXPOSURE DURING PREGNANCY |
222 |
0.0065 |
| 693 |
BURSITIS |
79 |
0.0065 |
| 694 |
PNEUMONIA ASPIRATION |
162 |
0.0065 |
| 695 |
CARDIOGENIC SHOCK |
92 |
0.0064 |
| 696 |
HAEMORRHOIDS |
125 |
0.0064 |
| 697 |
HAEMATOMA |
166 |
0.0064 |
| 698 |
ECZEMA |
335 |
0.0064 |
| 699 |
TENDON RUPTURE |
79 |
0.0064 |
| 700 |
MUSCULOSKELETAL DISCOMFORT |
110 |
0.0064 |
| 701 |
HAEMOPTYSIS |
178 |
0.0064 |
| 702 |
BLOOD SODIUM DECREASED |
120 |
0.0064 |
| 703 |
SWELLING |
595 |
0.0064 |
| 704 |
EAR INFECTION |
169 |
0.0063 |
| 705 |
APHASIA |
191 |
0.0063 |
| 706 |
RASH |
2754 |
0.0063 |
| 707 |
STEVENS-JOHNSON SYNDROME |
140 |
0.0063 |
| 708 |
PAIN IN EXTREMITY |
1848 |
0.0063 |
| 709 |
CHILLS |
735 |
0.0063 |
| 710 |
SENSORY DISTURBANCE |
100 |
0.0062 |
| 711 |
DISCOMFORT |
380 |
0.0062 |
| 712 |
CARDIOMYOPATHY |
92 |
0.0062 |
| 713 |
SKIN EXFOLIATION |
525 |
0.0062 |
| 714 |
CHOLELITHIASIS |
204 |
0.0062 |
| 715 |
DYSPHAGIA |
588 |
0.0062 |
| 716 |
TOOTH INFECTION |
81 |
0.0061 |
| 717 |
INCORRECT DOSE ADMINISTERED |
1397 |
0.0061 |
| 718 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1102 |
0.0061 |
| 719 |
EJECTION FRACTION DECREASED |
95 |
0.0061 |
| 720 |
GAIT INABILITY |
203 |
0.0061 |
| 721 |
ANKLE FRACTURE |
94 |
0.0061 |
| 722 |
HEADACHE |
3802 |
0.0061 |
| 723 |
NASAL CONGESTION |
355 |
0.0060 |
| 724 |
COLON CANCER |
90 |
0.0060 |
| 725 |
SKIN REACTION |
85 |
0.0060 |
| 726 |
MENTAL STATUS CHANGES |
167 |
0.0060 |
| 727 |
SKIN DISCOLOURATION |
275 |
0.0060 |
| 728 |
RASH PAPULAR |
134 |
0.0060 |
| 729 |
DRY MOUTH |
484 |
0.0060 |
| 730 |
ARTHRALGIA |
2474 |
0.0059 |
| 731 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
153 |
0.0059 |
| 732 |
OXYGEN SATURATION DECREASED |
334 |
0.0059 |
| 733 |
NEURALGIA |
144 |
0.0059 |
| 734 |
LIMB DISCOMFORT |
183 |
0.0059 |
| 735 |
MIGRAINE |
564 |
0.0059 |
| 736 |
COUGH |
1655 |
0.0059 |
| 737 |
HERNIA |
114 |
0.0059 |
| 738 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
101 |
0.0059 |
| 739 |
GALLBLADDER DISORDER |
105 |
0.0059 |
| 740 |
HIP ARTHROPLASTY |
90 |
0.0059 |
| 741 |
DIARRHOEA |
3784 |
0.0059 |
| 742 |
NASOPHARYNGITIS |
1079 |
0.0058 |
| 743 |
MYALGIA |
991 |
0.0058 |
| 744 |
THROAT IRRITATION |
261 |
0.0058 |
| 745 |
SURGERY |
341 |
0.0058 |
| 746 |
BLINDNESS UNILATERAL |
82 |
0.0058 |
| 747 |
CONTUSION |
558 |
0.0058 |
| 748 |
LIP SWELLING |
192 |
0.0058 |
| 749 |
EOSINOPHILIA |
101 |
0.0058 |
| 750 |
ORAL DISCOMFORT |
80 |
0.0058 |
| 751 |
ATRIAL FIBRILLATION |
549 |
0.0056 |
| 752 |
KIDNEY INFECTION |
110 |
0.0056 |
| 753 |
TOOTH DISORDER |
124 |
0.0056 |
| 754 |
GENERALISED TONIC-CLONIC SEIZURE |
92 |
0.0056 |
| 755 |
DERMATITIS ATOPIC |
293 |
0.0056 |
| 756 |
COLITIS ULCERATIVE |
248 |
0.0055 |
| 757 |
RIB FRACTURE |
114 |
0.0055 |
| 758 |
PRODUCT AVAILABILITY ISSUE |
126 |
0.0055 |
| 759 |
GASTRIC DISORDER |
189 |
0.0055 |
| 760 |
HYPONATRAEMIA |
309 |
0.0055 |
| 761 |
SLEEP DISORDER |
387 |
0.0055 |
| 762 |
RASH ERYTHEMATOUS |
261 |
0.0055 |
| 763 |
LOWER RESPIRATORY TRACT INFECTION |
248 |
0.0054 |
| 764 |
JOINT STIFFNESS |
143 |
0.0054 |
| 765 |
PANCREATITIS |
288 |
0.0054 |
| 766 |
CHROMATURIA |
123 |
0.0054 |
| 767 |
PAIN IN JAW |
154 |
0.0054 |
| 768 |
WEIGHT DECREASED |
1517 |
0.0054 |
| 769 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
159 |
0.0054 |
| 770 |
EMOTIONAL DISORDER |
167 |
0.0054 |
| 771 |
NEUROPATHY PERIPHERAL |
515 |
0.0054 |
| 772 |
BLOOD PRESSURE DECREASED |
358 |
0.0054 |
| 773 |
LIMB INJURY |
146 |
0.0054 |
| 774 |
IRRITABLE BOWEL SYNDROME |
115 |
0.0054 |
| 775 |
PAIN |
3290 |
0.0054 |
| 776 |
DYSARTHRIA |
201 |
0.0053 |
| 777 |
BLOOD PRESSURE ABNORMAL |
106 |
0.0053 |
| 778 |
MENTAL DISORDER |
232 |
0.0053 |
| 779 |
MATERNAL EXPOSURE DURING PREGNANCY |
474 |
0.0053 |
| 780 |
HEART RATE INCREASED |
526 |
0.0053 |
| 781 |
HYPOCALCAEMIA |
100 |
0.0053 |
| 782 |
ABDOMINAL DISCOMFORT |
885 |
0.0053 |
| 783 |
INTERVERTEBRAL DISC PROTRUSION |
115 |
0.0053 |
| 784 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1064 |
0.0052 |
| 785 |
SPINAL FRACTURE |
105 |
0.0052 |
| 786 |
TOOTHACHE |
94 |
0.0052 |
| 787 |
EPILEPSY |
158 |
0.0052 |
| 788 |
RESPIRATORY TRACT CONGESTION |
82 |
0.0052 |
| 789 |
NIGHT SWEATS |
166 |
0.0051 |
| 790 |
PRODUCT DISPENSING ERROR |
112 |
0.0051 |
| 791 |
FRACTURE |
97 |
0.0051 |
| 792 |
TACHYCARDIA |
455 |
0.0051 |
| 793 |
TREMOR |
850 |
0.0051 |
| 794 |
FOOT FRACTURE |
97 |
0.0051 |
| 795 |
HYPOKALAEMIA |
235 |
0.0051 |
| 796 |
VOMITING |
2388 |
0.0051 |
| 797 |
DYSPHONIA |
296 |
0.0051 |
| 798 |
TYPE 2 DIABETES MELLITUS |
170 |
0.0050 |
| 799 |
NEOPLASM MALIGNANT |
335 |
0.0050 |
| 800 |
MUSCLE SPASMS |
921 |
0.0050 |
| 801 |
DISORIENTATION |
198 |
0.0050 |
| 802 |
TINNITUS |
229 |
0.0050 |
| 803 |
DEEP VEIN THROMBOSIS |
322 |
0.0050 |
| 804 |
THERAPEUTIC RESPONSE UNEXPECTED |
222 |
0.0049 |
| 805 |
TASTE DISORDER |
100 |
0.0049 |
| 806 |
RASH MACULAR |
172 |
0.0049 |
| 807 |
INSOMNIA |
1309 |
0.0049 |
| 808 |
LABORATORY TEST ABNORMAL |
145 |
0.0049 |
| 809 |
ACUTE MYOCARDIAL INFARCTION |
144 |
0.0049 |
| 810 |
DEHYDRATION |
647 |
0.0048 |
| 811 |
BACK PAIN |
1124 |
0.0048 |
| 812 |
NAUSEA |
3828 |
0.0048 |
| 813 |
FLUID RETENTION |
246 |
0.0048 |
| 814 |
ILLNESS |
498 |
0.0048 |
| 815 |
CORONARY ARTERY DISEASE |
146 |
0.0048 |
| 816 |
HAEMATOCHEZIA |
266 |
0.0048 |
| 817 |
DYSGEUSIA |
358 |
0.0048 |
| 818 |
COMA |
228 |
0.0048 |
| 819 |
HALLUCINATION, VISUAL |
101 |
0.0048 |
| 820 |
FULL BLOOD COUNT DECREASED |
96 |
0.0048 |
| 821 |
ASTHENIA |
1790 |
0.0048 |
| 822 |
EATING DISORDER |
101 |
0.0047 |
| 823 |
DYSPNOEA |
2684 |
0.0047 |
| 824 |
GAIT DISTURBANCE |
907 |
0.0047 |
| 825 |
WEIGHT INCREASED |
1057 |
0.0047 |
| 826 |
ANGINA PECTORIS |
135 |
0.0047 |
| 827 |
RENAL INJURY |
139 |
0.0047 |
| 828 |
KNEE ARTHROPLASTY |
98 |
0.0047 |
| 829 |
HEART RATE DECREASED |
163 |
0.0046 |
| 830 |
GASTROOESOPHAGEAL REFLUX DISEASE |
373 |
0.0046 |
| 831 |
TOXICITY TO VARIOUS AGENTS |
781 |
0.0046 |
| 832 |
SWOLLEN TONGUE |
144 |
0.0046 |
| 833 |
FATIGUE |
3585 |
0.0046 |
| 834 |
MALAISE |
2008 |
0.0046 |
| 835 |
DISABILITY |
90 |
0.0045 |
| 836 |
HAEMORRHAGE |
475 |
0.0045 |
| 837 |
PRODUCT COMPLAINT |
115 |
0.0045 |
| 838 |
CARDIOVASCULAR DISORDER |
115 |
0.0045 |
| 839 |
URINARY INCONTINENCE |
134 |
0.0045 |
| 840 |
CONFUSIONAL STATE |
729 |
0.0045 |
| 841 |
HYPOAESTHESIA |
673 |
0.0045 |
| 842 |
ILL-DEFINED DISORDER |
272 |
0.0045 |
| 843 |
INTESTINAL OBSTRUCTION |
168 |
0.0045 |
| 844 |
BONE DISORDER |
81 |
0.0044 |
| 845 |
BONE PAIN |
260 |
0.0044 |
| 846 |
ABDOMINAL DISTENSION |
462 |
0.0044 |
| 847 |
HYPOPHAGIA |
113 |
0.0044 |
| 848 |
PULMONARY EMBOLISM |
419 |
0.0044 |
| 849 |
ADVERSE DRUG REACTION |
396 |
0.0044 |
| 850 |
FALL |
1464 |
0.0044 |
| 851 |
CARDIAC ARREST |
361 |
0.0044 |
| 852 |
SPEECH DISORDER |
229 |
0.0044 |
| 853 |
HYPOTENSION |
876 |
0.0044 |
| 854 |
ADVERSE EVENT |
401 |
0.0043 |
| 855 |
DRUG DOSE OMISSION |
719 |
0.0043 |
| 856 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
158 |
0.0043 |
| 857 |
HAEMATEMESIS |
110 |
0.0043 |
| 858 |
ARRHYTHMIA |
205 |
0.0043 |
| 859 |
COGNITIVE DISORDER |
200 |
0.0043 |
| 860 |
DECREASED APPETITE |
986 |
0.0042 |
| 861 |
FAECES DISCOLOURED |
92 |
0.0042 |
| 862 |
CYTOKINE RELEASE SYNDROME |
85 |
0.0042 |
| 863 |
CHEST PAIN |
775 |
0.0042 |
| 864 |
DELIRIUM |
144 |
0.0041 |
| 865 |
NEPHROLITHIASIS |
190 |
0.0041 |
| 866 |
MOVEMENT DISORDER |
133 |
0.0041 |
| 867 |
INTENTIONAL DOSE OMISSION |
118 |
0.0041 |
| 868 |
THROMBOSIS |
332 |
0.0041 |
| 869 |
MUSCLE TWITCHING |
95 |
0.0041 |
| 870 |
DYSPEPSIA |
405 |
0.0041 |
| 871 |
BALANCE DISORDER |
354 |
0.0041 |
| 872 |
PARAESTHESIA |
641 |
0.0041 |
| 873 |
HALLUCINATION |
307 |
0.0041 |
| 874 |
PRODUCT DOSE OMISSION ISSUE |
1196 |
0.0041 |
| 875 |
VERTIGO |
247 |
0.0040 |
| 876 |
THERAPY INTERRUPTED |
288 |
0.0040 |
| 877 |
HIP FRACTURE |
129 |
0.0040 |
| 878 |
SEIZURE |
462 |
0.0040 |
| 879 |
LOSS OF CONSCIOUSNESS |
511 |
0.0040 |
| 880 |
FEELING HOT |
243 |
0.0040 |
| 881 |
WHEEZING |
234 |
0.0039 |
| 882 |
POLLAKIURIA |
164 |
0.0039 |
| 883 |
ANAPHYLACTIC SHOCK |
101 |
0.0039 |
| 884 |
HOT FLUSH |
295 |
0.0039 |
| 885 |
DRY SKIN |
518 |
0.0039 |
| 886 |
DYSSTASIA |
113 |
0.0039 |
| 887 |
FEELING ABNORMAL |
927 |
0.0039 |
| 888 |
FOETAL EXPOSURE DURING PREGNANCY |
313 |
0.0038 |
| 889 |
ABDOMINAL PAIN UPPER |
792 |
0.0038 |
| 890 |
INJURY |
270 |
0.0038 |
| 891 |
PRURITUS GENERALISED |
83 |
0.0038 |
| 892 |
THERAPEUTIC RESPONSE SHORTENED |
127 |
0.0038 |
| 893 |
CHEST DISCOMFORT |
392 |
0.0038 |
| 894 |
AMNESIA |
249 |
0.0038 |
| 895 |
BLOOD POTASSIUM DECREASED |
115 |
0.0038 |
| 896 |
ASTHMA |
431 |
0.0038 |
| 897 |
AGEUSIA |
95 |
0.0038 |
| 898 |
ACCIDENTAL OVERDOSE |
138 |
0.0038 |
| 899 |
LETHARGY |
217 |
0.0038 |
| 900 |
PSYCHOTIC DISORDER |
111 |
0.0038 |
| 901 |
CONSTIPATION |
815 |
0.0037 |
| 902 |
HYPOACUSIS |
160 |
0.0037 |
| 903 |
RASH GENERALISED |
96 |
0.0037 |
| 904 |
URINARY RETENTION |
123 |
0.0037 |
| 905 |
TRANSIENT ISCHAEMIC ATTACK |
123 |
0.0036 |
| 906 |
DIZZINESS |
1818 |
0.0036 |
| 907 |
PALLOR |
99 |
0.0036 |
| 908 |
INTENTIONAL PRODUCT MISUSE |
318 |
0.0036 |
| 909 |
HEART RATE IRREGULAR |
82 |
0.0036 |
| 910 |
HEAD INJURY |
114 |
0.0036 |
| 911 |
CARDIAC FAILURE CONGESTIVE |
287 |
0.0036 |
| 912 |
ABASIA |
88 |
0.0036 |
| 913 |
NERVOUSNESS |
184 |
0.0035 |
| 914 |
FEELING COLD |
98 |
0.0035 |
| 915 |
ABDOMINAL PAIN LOWER |
89 |
0.0035 |
| 916 |
TREATMENT NONCOMPLIANCE |
192 |
0.0035 |
| 917 |
DEMENTIA |
98 |
0.0035 |
| 918 |
DRUG EFFECT INCOMPLETE |
127 |
0.0035 |
| 919 |
FLATULENCE |
197 |
0.0035 |
| 920 |
RECTAL HAEMORRHAGE |
149 |
0.0035 |
| 921 |
CRYING |
126 |
0.0035 |
| 922 |
DISTURBANCE IN ATTENTION |
186 |
0.0034 |
| 923 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
80 |
0.0034 |
| 924 |
THROAT TIGHTNESS |
92 |
0.0034 |
| 925 |
BRADYCARDIA |
180 |
0.0034 |
| 926 |
DEPRESSION |
772 |
0.0034 |
| 927 |
LUNG NEOPLASM MALIGNANT |
139 |
0.0034 |
| 928 |
ROAD TRAFFIC ACCIDENT |
140 |
0.0033 |
| 929 |
EXPOSURE DURING PREGNANCY |
206 |
0.0033 |
| 930 |
ANXIETY |
932 |
0.0033 |
| 931 |
UNEVALUABLE EVENT |
247 |
0.0033 |
| 932 |
PLASMA CELL MYELOMA |
127 |
0.0033 |
| 933 |
DEPRESSED MOOD |
172 |
0.0033 |
| 934 |
MEMORY IMPAIRMENT |
447 |
0.0033 |
| 935 |
SKIN IRRITATION |
148 |
0.0032 |
| 936 |
CARDIO-RESPIRATORY ARREST |
135 |
0.0032 |
| 937 |
PALPITATIONS |
372 |
0.0032 |
| 938 |
INTERNATIONAL NORMALISED RATIO INCREASED |
90 |
0.0032 |
| 939 |
SOMNOLENCE |
634 |
0.0031 |
| 940 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
79 |
0.0031 |
| 941 |
FEMUR FRACTURE |
96 |
0.0031 |
| 942 |
FREQUENT BOWEL MOVEMENTS |
83 |
0.0031 |
| 943 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
159 |
0.0030 |
| 944 |
INFLUENZA LIKE ILLNESS |
250 |
0.0030 |
| 945 |
ABORTION SPONTANEOUS |
121 |
0.0030 |
| 946 |
CARDIAC DISORDER |
280 |
0.0030 |
| 947 |
SYNCOPE |
296 |
0.0030 |
| 948 |
HYPERHIDROSIS |
379 |
0.0029 |
| 949 |
DEATH |
2521 |
0.0029 |
| 950 |
DRUG ADMINISTRATION ERROR |
89 |
0.0029 |
| 951 |
HYPERSOMNIA |
83 |
0.0029 |
| 952 |
MYOCARDIAL INFARCTION |
501 |
0.0029 |
| 953 |
PANIC ATTACK |
103 |
0.0028 |
| 954 |
SKIN BURNING SENSATION |
202 |
0.0028 |
| 955 |
HYPOGLYCAEMIA |
136 |
0.0028 |
| 956 |
DRUG EFFECT DECREASED |
150 |
0.0028 |
| 957 |
CEREBROVASCULAR ACCIDENT |
461 |
0.0027 |
| 958 |
INJECTION SITE REACTION |
187 |
0.0027 |
| 959 |
MEDICATION ERROR |
151 |
0.0027 |
| 960 |
PRODUCT QUALITY ISSUE |
363 |
0.0027 |
| 961 |
AGITATION |
194 |
0.0026 |
| 962 |
INJECTION SITE BRUISING |
209 |
0.0026 |
| 963 |
DYSKINESIA |
103 |
0.0025 |
| 964 |
NEOPLASM PROGRESSION |
88 |
0.0025 |
| 965 |
RESTLESSNESS |
91 |
0.0025 |
| 966 |
PRODUCT SUBSTITUTION ISSUE |
141 |
0.0024 |
| 967 |
MALIGNANT NEOPLASM PROGRESSION |
246 |
0.0024 |
| 968 |
IRRITABILITY |
142 |
0.0024 |
| 969 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
79 |
0.0023 |
| 970 |
FLUSHING |
237 |
0.0023 |
| 971 |
HOSPITALISATION |
355 |
0.0023 |
| 972 |
EMOTIONAL DISTRESS |
274 |
0.0023 |
| 973 |
BLOOD GLUCOSE INCREASED |
413 |
0.0022 |
| 974 |
SUICIDAL IDEATION |
199 |
0.0022 |
| 975 |
INJECTION SITE SWELLING |
166 |
0.0022 |
| 976 |
OVERDOSE |
454 |
0.0021 |
| 977 |
ABNORMAL BEHAVIOUR |
83 |
0.0021 |
| 978 |
INJECTION SITE PRURITUS |
135 |
0.0020 |
| 979 |
INJECTION SITE HAEMORRHAGE |
159 |
0.0020 |
| 980 |
INJECTION SITE ERYTHEMA |
233 |
0.0019 |
| 981 |
UNDERDOSE |
135 |
0.0018 |
| 982 |
INJECTION SITE PAIN |
564 |
0.0018 |
| 983 |
BREAST CANCER |
168 |
0.0018 |
| 984 |
MULTIPLE SCLEROSIS |
86 |
0.0018 |
| 985 |
NO ADVERSE EVENT |
320 |
0.0018 |
| 986 |
BLOOD GLUCOSE DECREASED |
84 |
0.0017 |
| 987 |
DEVICE ISSUE |
150 |
0.0017 |
| 988 |
DEVICE MALFUNCTION |
107 |
0.0015 |
| 989 |
DRUG DEPENDENCE |
117 |
0.0007 |